Baillie Gifford - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 90 filers reported holding VYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$65,000
-35.6%
98,7620.0%0.00%
Q4 2021$101,000
-26.8%
98,7620.0%0.00%
Q3 2021$138,000
-60.2%
98,7620.0%0.00%
Q2 2021$347,000
-48.7%
98,7620.0%0.00%
Q1 2021$676,00098,7620.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,551,000$2,602,0002.01%
Perceptive Advisors 4,356,044$4,444,0000.03%
GSA CAPITAL PARTNERS LLP 217,747$222,0000.03%
Virtu Financial LLC 175,278$179,0000.02%
XTX Topco Ltd 17,053$17,0000.01%
SkyOak Wealth, LLC 27,200$28,0000.01%
DELTEC ASSET MANAGEMENT LLC 30,000$31,0000.01%
Tekla Capital Management LLC 135,395$138,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$64,0000.00%
TWO SIGMA SECURITIES, LLC 47,475$48,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders